Did an Alzheimer’s drug give Sue and Ken Bell more time? Maybe
(By Jon Hamilton for NPR) In 2020, Sue Bell became one of the first Alzheimer’s patients in the U.S. to
Read More(By Jon Hamilton for NPR) In 2020, Sue Bell became one of the first Alzheimer’s patients in the U.S. to
Read More(By Alexandra Murphy for Becker’s Hospital Review) Leqembi, an Alzheimer’s drug from Biogen and Eisai, faces hurdles with respect to
Read More(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read MoreThe FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More